Advertisement |
Integrated Payer-Provide Networks are motivated to influence MD behavior.
Read this article to learn what you need to know about how to influence IPPNs. |
|
Advertisement |
Tufts CSDD Study Offers New Model to Maximise Sponsor-CRO Partnerships Learn how to foster a shared vision that enables you to effectively harness multidisciplinary expertise across partnerships with Tufts CSDD's integrated, patient-centric approach to creating impactful operational strategies.
Learn more |
|
Q&A |
 |
Research Data Promise Vs. Reality |
Michael Christel speaks to Ken Getz of the Tufts Center for the Study of Drug Development, who outlines how the convergence of health data and technology will be key to lasting gains for clinical research
... /Read more/ |
|
|
Advertisement |
Considering changing product access vendors? Watch this brief video to learn an effective 4-point methodology to optimize your program transition by addressing data conversion, implementation planning, stakeholder communications, and technology.
Learn more |
|
Special Feature |
 |
Pharm Exec's Top 50 Companies |
Pharm Exec's 16th annual listing of the top biopharma players may look placid on the surface, but, upon deeper inspection, does point to important transitions taking place in the larger business model.
... /Read more/ |
|
|
Advertisement |
Breaking the Circle of Distrust with a Radical PLC Pricing Model
LIVE WEBCAST: Thursday, June 30, 2016 at 10 am EDT | 3 pm BST | 4 pm CEST
Free registration |
|
|
Calendar |
|
|
Advertisement |
Best Practices for Integrating Biomarkers
across the Drug Development Continuum
On Demand
Learn more |
|
|
 |
Advertisement |
Considering Biosimilars: A Panel Discussion Exploring Perceptions and Potential Adoption
On Demand
Learn more |
|
Industry update |
//Aprea AB (Stockholm, Sweden and Boston, MA) named Christian S. Schade as President and Chief Executive Officer.//MedAvante, Inc. (Hamilton, NJ) announced two new members of its Board of Directors: Richard F. Cimino, former Covance EVP and Group President of Clinical Development and Commercialization Services, and Nigel Brown, former Corporate Vice President of Business Development and Strategy at Covance.//Adherium Limited (Melbourne, Australia) announced the establishment of Adherium North America, Inc., based in San Francisco, CA, and appointed James Hattersley as Senior Vice President of Business Development, North America.// |
Advertisement |
Strategic considerations for clinical development programs in emerging biopharma companies
On Demand
Learn more |
|
|
|